55 results
8-K
EX-99.1
BPMC
Blueprint Medicines Corp
2 May 24
Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
7:09am
Blueprint’s 2023 progress on environmental, social, and governance (ESG) initiatives and strategy and reflecting the results of a materiality
8-K
EX-99.2
wal14 0bgoo
17 Aug 22
Other Events
7:28am
8-K
EX-2.1
ixnicd qfk30
30 Dec 21
Blueprint Medicines Completes Acquisition of Lengo Therapeutics
9:11am